Environmental tobacco smoke and stress as risk factors for miscarriage and preterm births by unknown
GENERAL GYNECOLOGY
Environmental tobacco smoke and stress as risk factors
for miscarriage and preterm births
Farha Arffin • Fouad H. AL-Bayaty •
Jamiyah Hassan
Received: 14 January 2012 / Accepted: 4 June 2012
 The Author(s) 2012. This article is published with open access at Springerlink.com
Abstract
Back ground Exposure of pregnant women to environ-
mental tobacco smoke has been shown to be associated
with low birth weight. Many studies have suggested that
stress have a role in the etiology of preterm birth.
Aims This study carried out from June 2008 to March
2009 to find the relation between environmental tobacco
smoke, stress and miscarriage and preterm births.
Methods A total of 33 subjects consisted of multiparous
pregnant women that were in their early third trimester
were chosen for this investigation. Subjects were divided
into test group women with adverse pregnancy outcome,
control group women with successful pregnancy. Four ml
of unstimulated whole saliva were collected. The concen-
trations of cotinine and cortisol were evaluated using
commercially available ELISA kit.
Results Pregnancies in which the average standardized
cortisol during history of previous miscarriage(s) which
occurred within 6th–27th week or/and history of preterm
labor which occurred within 28th–36th weeks of gestation,
demonstrated higher cortisol level (1.0201 ± 0.1855 ng/ml)
compared to control group 0.9757 ± 0.2860 ng/ml (P =0.323);
statistical analysis showed no significant differences.
Women of control group were more likely to be environ-
mental tobacco smoke exposed (1.2714 ± 1.7639 ng/ml)
than women with miscarriage and preterm births (0.9889 ±
0.5498 ng/ml).
Conclusion The results from this primarily study dem-
onstrated no association between cotinine, cortisol, mis-
carriage and preterm births.
Keywords Environmental tobacco smoke  Stress 
Miscarriage  Preterm births
Introduction
There is growing awareness of the harmful effects of
smoking during pregnancy. Smoking, through exposure to
substances like nicotine and carbon monoxide, is associ-
ated with a number of serious complications during preg-
nancy, including increased rates of spontaneous abortion
[1], premature delivery [1, 2] and low birth weight [1].
According to WHO/ICD, miscarriage is defined as the
death of fetus before 22 weeks of gestation or a fetus
delivered weighing less than 500 g, so the preterm birth
will include delivery after 22 weeks and before 37 weeks
of gestation.
Exposure of pregnant women to environmental tobacco
smoke has been shown to be associated with low birth weight
in the infants of exposed non-smoking mothers [2, 3], and to
have an added negative effect on the infant’s birth weight in
smoking mothers [2]. Smoking during pregnancy also leads
to an increased infant death rate around the time of birth
(perinatal mortality) [4], up to one and a half times the
average rate [2]. Studies of environmental tobacco smoke
(ETS) and risk of spontaneous abortion are limited to a few
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studies of self-reported exposure to ETS or paternal smoke,
and the results have been inconsistent [5–7]. Studies based
on self-reported ETS exposure probably provide even larger
validity concerns than self-reported active smoking and do
not properly account for all possible exposures at home,
work, and in public places [8, 9]. Measurement of cotinine, a
biomarker of nicotine, has been shown to be a valid summary
measure of the dose received from ETS as well as from active
smoking [8–10].
Cortisol is commonly used as a stress marker because its
production by the adrenal cortex tends to increase as a
result of energetic, immunological, and psychological
challenges [11, 12]. There is growing evidence that psy-
chological, social and economic stresses increase risks of
preterm birth and prenatal mortality. It is postulated that
stress-induced elevations in cortisol and catecholamine
alter the immune response and increase free placental
corticotrophin-releasing hormone (CRH) that may act as an
uterotonic agent [13]. Many studies have suggested that
stress and stress hormones have a role in the etiology of
preterm birth (PTB) [11–13].
Oral fluid has attracted widespread interest as a diag-
nostic medium for rapid, point-of-care testing [14–16].
Saliva has been considered a ‘‘mirror of the body’’ that
generally reflects the state of a patient’s overall health.
There is growing interest in the use of human whole saliva
for diagnostics and disease monitoring as an alternative to
blood samples. In contrast to blood, whole saliva is a non-
sterile body fluid. Proper handling and storage are required
to preserve the integrity of potential biomarkers [17]. The
advantages of using saliva for disease diagnostics include
ease of access, noninvasive sample collection, increased
acceptance by patients, and reduced risks of infectious
disease transmission [16]. Oral samples are readily acces-
sible as whole saliva or by sampling secretions from spe-
cific glands. The aim of the study was to evaluate the
association between ETS and stress as assessed by salivary




This was a cross-sectional study carried out in Malaysia,
Kuala Lumpur over 9 months, from June 2008 to March
2009. A total of 250 pregnant women who had their
antenatal check-up at the Antenatal Clinic, University
Malaya Medical Centre (UMMC) were examined prior to
being referred to The Periodontal Postgraduate Clinic,
Faculty of Dentistry, University of Malaya for saliva
collection. Sixty-three subjects who fulfilled a set of
inclusion and exclusion criteria were only eligible for this
study.
Thirty-three volunteered pregnant women agreed to
participate in this study. Women gave informed consent for
all aspects of the study, which was approved by the Ethical
Committee. The study protocol was approved by The
Medical Ethics Committee of UMMC (No: 607.1) and The
Ethical Committee Board of the Faculty of Dentistry,
University of Malaya (No: DF OP0706/0029 (P), a).
Medical records
The medical records of all subjects were gathered from the
Antenatal Clinic of UMMC. The information collected
included history of previous pregnancy, expected date of
delivery (EDD), patient’s medical status and presence of
gestational diabetes in current pregnancy. The presence of
serious medical or systemic condition will exclude sample
participation in the study.
Based on the information in the medical records, sub-
jects were divided into two groups:
1. Test group: Women with miscarriage and preterm
births, 18 of healthy pregnant women who had history
of previous miscarriage(s) which occurred within 6th–
27th week or/and history of preterm labor which
occurred within 28th–36th week of gestation.
2. Control group: Women with successful pregnancy, 14
healthy pregnant women who had no previous miscar-
riage or preterm delivery at more than 36 weeks.
Inclusion and exclusion criteria
Thirty-three pregnant women registered at the Antenatal
Clinic, UMMC aged between 23- and 39-years old were
selected for the study. The inclusion criteria were gesta-
tional age between 24 and 32 weeks and multiparous. The
exclusion criteria were: smoking active or passive at work
or at home, drug abuse such as prednisone, dexamethasone,
medical or systemic conditions such as cardiovascular
disease, respiratory problem, diabetes mellitus, kidney
disease, hematological disorder and other chronic diseases,
gestational diabetes and multiple foetuses.
The selected subjects were asked to fill a questionnaire
which included information on age, ethnicity, EDD, current
body weight, gestational weight gain, occupation, and
pregnancy history. Subjects were asked to spit into sterile
plastic tubes to collect 4 ml of unstimulated whole saliva
which was then kept frozen at -80 C until analyzed. The
collection of the saliva was standardized before 12:00 p.m.
to avoid differences caused by circadian rhythm.
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Enzyme-Linked Immunosorbent Assay Technique
(ELISA)
The concentrations of cotinine and cortisol from the saliva
samples were evaluated using commercially available
ELISA kit (NANO LIFE QUEST SDN. BHD. SIGMA,
GERMANY). ELISA technique is a biochemical procedure
to detect the presence of an antibody or antigen from any
sample such as plasma, vaginal fluid or saliva. Basically,
this technique involves an affixation of an antigen of
unknown amount to a microwell surface which has been
pre-coated with an antibody specific for the antigen in
question.
Statistical analysis
Statistical Package for Social Science (SPSS) Version 16.0
was used to analyze the results. Since the cotinine and
cortisol levels in the saliva displayed a non-normal distri-
bution, the Mann–Whitney test was used to determine the
significance of the difference between the test and control
groups, for which the statistical significance was set for a
p value of B0.05.
Results
Sample population
A total of 33 subjects consisted of multiparous pregnant
married Malaysian women (Malayan ethnicity) that were in
their early third trimester were chosen for this investiga-
tion. The age range of the subjects was between 23- and
39-years old with a mean age of 29.8 (±3.6) years. The
mean age for the test group was 29.3 and for control group
was 30.7. All subjects were Malay government employers.
Women with miscarriage and preterm births and women in
successful pregnancy group had approximately the same
age. Table 1 showed the demographic distribution of the
sample.
Results demonstrated that saliva cotinine level was
higher in control group (0.7485 ± SEM 0.1589 lg/ml)
compared with test group (0.6776 ± SEM 0.2658 lg/ml).
Women control group were more likely to be ETS-exposed
than women with miscarriage and preterm births. statistical
analysis showed no significant differences (Table 2).
Figure 1 demonstrates the comparative history of miscar-
riage and preterm births according to ETS-exposed by
evaluating cotinine level in both groups. There were two
outliers in test group and one outlier in control group. The
level of cotinine for these three outliers is very much low
compared to other subjects in each group. Results also
show no significant differences.
We calculated the comparative history of miscarriage and
preterm births according to cortisol exposure. Pregnancies in
which the average standardized cortisol during history of
previous miscarriage(s) which occurred within 6th–27th
week or/and history of preterm labor which occurred within
28th–36th weeks of gestation, demonstrated higher cortisol







Age 33 29.3 ± 4.0 30.7 ± 3.0
Race
Malay 33 20 (100 %) 13 (100 %)
Marital status 33
i. Single 0 0




i. \5 kg 1 2
ii. 6–10 kg 7 6
iii. 10–20 kg 3 4
iv. 20–30 kg 4 0







Table 2 Cotinine level in test and control groups
Group n Mean ± SEM (lg/ml) Median (lg/ml) p value
Test 20 0.6776 ± 0.2658 0.7150 0.598*
Control 13 0.748 5 ± 0.1589 0.8200
* Mann–Whitney Test




level (1.016 ± SEM 0.182 lg/ml) compared to control
group 0.978 ± SEM 0.298 lg/ml (P = 0.392), normal
morning levels of saliva cortisol is 0.99 ± 0.42 lg/100 ml,
however, statistical analysis showed no significant differ-
ences. [Table 3, Fig. 2]. As for the cotinine, there were also
outliers in each group. However, the levels of cortisol for
these outliers were higher compared to other subjects in the
groups.
Discussion
To our knowledge, there are a few studies on the relation
between ETS and stress as risk for miscarriage and preterm
births based on cotinine and cortisol measurements. In recent
years, there has been growing knowledge and awareness
of the dangers and serious adverse health effects of envi-
ronmental tobacco smoke exposure. Non-smokers hotel
workers in London show saliva cotinine level (0.5 ng/ml)
[18]. The health hazards of environmental tobacco smoke
exposure affect almost every organ and system in the body
with a wide spectrum of ailments and diseases, and it has
been clearly implicated as the cause of death in many of those
who were exposed to it [19]. Environmental tobacco smoke
exposure acquires special importance when it comes to
considering the negative health impact on children.
There is much evidence to show that smoking compli-
cates the course of pregnancy, endangers the life of the
mother, threatens the life of the fetus, and places the
newborn at great risk of immediate and long-term com-
plications, and possibly even death [20].
We found that women with successful pregnancy and
women with miscarriage and preterm births were exposed
to ETS. We decided a priori to exclude smoking women
and women using oral snuff or nicotine replacement ther-
apy. Our finding showed that women with successful
pregnancy outcome represent higher level of cotinine in
their saliva samples. Statistical analysis could not show a
significant differential effect of exposure to ETS. This may
because the power to study miscarriage and preterm births
was limited, because our sample included only 13 cases
with normal and 20 with abnormal pregnancy. The biologic
mechanisms underlying a possible association between
ETS and miscarriage and preterm births may involve
pathways similar to those for active smoking, because side
stream tobacco smoke contains many of the same constit-
uents as mainstream tobacco smoke [18]. Several compo-
nents of tobacco smoke (e.g, nicotine, carbon monoxide,
and cyanide) are toxic for the developing fetus. Nicotine
has vasoconstrictive effects leading to reduced placental
blood flow [19]. Carbon monoxide binds to hemoglobin,
causing maternal and fetal hypoxia, which may interfere
with the development of the growing fetus and induce fetal
death. Research indicates that later in pregnancy, smoking
does appear to decrease the placenta’s ability to deliver
nutrients to the developing baby. In addition to potentially
causing miscarriages, this can cause babies to be born with
lower birth weight and can also increase the risk of still-
birth, as well as death in the first year of life [18, 20].
Researchers found that 90 percent of women, whose
ages ranged from 18 to 34, with elevated levels of the
stress-induced hormone miscarriage during the first
3 weeks of pregnancy, compared to 33 percent of those
with normal levels. Researchers suggest that the body may
recognize elevated cortisol levels as an alarm that condi-
tions are unfavorable for pregnancy [21, 22].
Maternal stress is commonly cited as a potential cause
for at least part of pregnancy losses that remain ‘‘unex-
plained’’ [21–23]. Yet, for humans, little physiological
evidence exists in support of this hypothesis [24, 25].
Our finding of an association between increased maternal
cortisol and higher risk of miscarriage and preterm births,
together with previous research has failed to find such an
association [25]. Cortisol secretion can be affected by
circadian rhythms, physical activity, food consumption,
smoking, caffeine, alcohol, and steroid medications [26–28].
None of our participants smoked or consumed alcohol.
Cortisol levels may be affected by age [29]; the lack of an
effect of age on cortisol may be due to the youthfulness of our
Table 3 Cortisol level in test and control groups
Group n Mean ± SEM (lg/ml) Median (lg/ml) p value
Test 20 1.016 ± 0.182 0.977 0.392*
Control 13 0.978 ± 0.298 0.932
* Mann–Whitney Test




sample. The 32 women who conceived during the study
ranged from 23 to 39 years, but the age distribution was
heavily weighted toward the early twenties.
Conclusion
Results demonstrated no association between cotinine,
cortisol miscarriage and preterm births. Future longitudinal
studies with larger samples will be necessary to compare
cortisol and cotinine levels as risk factors for miscarriage
and preterm births across the entire duration of gestation.
Further research will also be necessary to explore the
physiological pathways that might mediate the observed
association.
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